doi: 10.3389/fneur.2023.1056341 Received 28 September 2022 Accepted 02 January 2023 Published 16 January 2023 Volume 14 - 2023 Edited by Jian-Quan Shi, Nanjing Medical University, China Reviewed by Tomas Marek, Mayo Clinic, United States
Studies investigating BPC-157 brain injury models, such as traumatic brain injury (TBI) in rats, have found that its administration can reduce neuronal damage, mitigate cerebral edema, and improve functional outcomes
Active Ingredients: Vitamin E (as DL-a-Tocopheryl Acetate) 22.5mg, Riboflavin (Vitamin B2) 8mg, Selenium (from 3.75mcg Selenomethionine) 1.5mcg
Cbi-Ex4 enhances glycemic control without inducing emesis or anorexia
The study findings suggest that clinicians may consider GLP-1 medications for those living with both type 2 diabetes and PAD, particularly individuals at higher risk